Figure 4From: Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomasMean doses and REDs for evaluated organs. Ratio of mean organ doses (A) and RED (B) for IMRT and PBT to those for CRT.Back to article page